Fertility-sparing treatment in advanced-stage serous borderline ovarian tumors. An analysis from the MITO14 study database

Francesca Falcone,Enrico Breda,Gabriella Ferrandina,Mario Malzoni,Anna M Perrone,Gennaro Cormio,Violante Di Donato,Luigi Frigerio,Giorgia Mangili,Francesco Raspagliesi,Anna Festi,Giuseppe Scibilia,Nicoletta Biglia,Roberto Sorio,Enrico Vizza,Nunzia S Losito,Stefano Greggi

Gynecologic Oncology（2021）

引用 5|浏览7

暂无评分

摘要

•Despite the high rate of recurrence, FSS provides good reproductive outcomes without a negative impact on overall survival.•The presence of invasive peritoneal implants affects the disease-free outcome with no impact on overall survival.•Advanced-stage serous BOTs can be safely selected for fertility-preservation management.

查看译文

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要